Weight-Loss drug candidate put through its paces in early dosing study

This early-stage study tested a single injection of petrelintide, a potential weight-management drug, in 48 adults with a BMI of 27 or higher. Researchers wanted to see if using different concentrations of the drug changed how the body processes it or affected safety. Participants made 10 clinic visits over about 50 days, including one 4-day stay. The study is complete, and results will help guide future dosing.